Colleen Collins

Baloxavir Marboxil (BXM) Treatment of Influenza in Renally Impaired Patients: Post Hoc Analysis of CAPSTONE-2

Colleen Collins, Steven E. Cagas, Jian Wei Han, Marie‐Laure Delporte et autres

Background: Renally impaired patients (pts) have a higher mortality rate from influenza vs pts without renal impairment. In the US, oseltamivir (OSL) is used for influenza but requires dose adjustment for pts with creatinine clearance (CrCl) <60 mL/min. CAPSTONE-2 (NCT02949011), a global …

ch, fr (code pays fourni par la source)

Safety and Efficacy of Baloxavir Marboxil in Influenza-infected Children 5–11 Years of Age: A Post Hoc Analysis of a Phase 3 Study

Jeffery B. Baker, Steven E. Cagas, Laura Burleigh Macutkiewicz, Colleen Collins et autres

BACKGROUND: miniSTONE-2 (NCT03629184) was a global, phase 3, randomized, controlled study that investigated the safety and efficacy of single-dose baloxavir marboxil in otherwise healthy children 1-<12 years of age and showed a positive risk-benefit profile. This post hoc analysis evaluated the safety …

us, gb (code pays fourni par la source)

BALOXAVIR MARBOXIL FOR THE TREATMENT OF INFLUENZA VIRUS INFECTION IN PATIENTS WITH CARDIOVASCULAR DISEASE: A SUBGROUP ANALYSIS OF CAPSTONE-2

Colleen Collins, Jian Wei Han, Steven E. Cagas, John R. Stephens et autres

ch (code pays fourni par la source)